Key Decisions in HIV Care: Choosing ART for Pediatric Patients
Listen as Dr Michelle D. Collins-Ogle shares some of the key considerations for choosing ART for pediatric patients, including for HIV-exposed newborns and children and adolescents infected with HIV.
Decera Clinical Education Infectious Disease Podcast · Michelle D. Collins-Ogle MD FAAP FPIDS AAHIVS, Michelle D. Collins-Ogle MD
Audio is streamed directly from the publisher (afp-928689-injected.calisto.simplecastaudio.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
In this episode, Michelle D. Collins-Ogle, MD, FAAP, FPIDS, AAHIVS, explores key considerations for choosing antiretroviral therapy (ART) for pediatric patients.
Listen as she gives perspectives on:
- Department of Health and Human Services (DHHS) guideline recommendations for infants at risk for perinatal HIV transmission
- DHHS guideline–recommended ART regimens for children
- The ODYSSEY A and B studies evaluating dolutegravir-based ART in children and adolescents
- Data for the use of the fixed-dose combination bictegravir/emtricitabine/tenofovir alafenamide in children and adolescents
- Key ART and management considerations for adolescents and young adults with HIV
Presenter:
Michelle D. Collins-Ogle, MD, FAAP, FPIDS, AAHIVS
Assistant Professor of Pediatrics
Division of Pediatric Infectious Diseases
Pediatric and Adolescent HIV
Children’s Hospital at Montefiore
Pediatric Hospital of Albert Einstein
College of Medicine
Bronx, New York
Follow along with the slides at:
https://bit.ly/3wMur29
Link to full program:
https://bit.ly/3fOl0XX
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.